Literature DB >> 21891913

Cemento-ossifying fibroma.

Chandramani More1, Krushna Thakkar, Mukesh Asrani.   

Abstract

Cemento-ossifying fibromas (COFs) are benign lesions affecting the jaws and other craniofacial bones. They commonly affect adult females between the third and fourth decade of life, predominantly occurring in the premolar/molar region of the mandible. Most of the lesions typically show slow and often expansile growth, centrally within the jaw and characteristically behave in a benign form, but occasionally they may present as an aggressive gigantiform lesion. Radiographically, they appear as well-defined unilocular or multilocular intraosseous masses. The lesion is invariably encapsulated and of mixed radiolucent densities. The tumor may grow quite extensively; thus, the term "aggressive" is sometimes applied. Surgical resection is the treatment of choice. They are insensitive to radiotherapy and recurrences are uncommon. Clinical, radiographic and histopathologic features of COF and other fibro-osseous lesions are overlapping and may cause confusion in classification, diagnosis and treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21891913     DOI: 10.4103/0970-9290.84296

Source DB:  PubMed          Journal:  Indian J Dent Res        ISSN: 0970-9290


  3 in total

1.  Pericoronal occurrence of cemento-ossifying fibroma: an unexemplified and unusual case report with review of literature.

Authors:  Kumaraswamy K L; Arvind Babu R S; Sheshadri P; Santhosh Kumaran
Journal:  J Clin Diagn Res       Date:  2014-03-15

2.  Cemento-Ossifying Fibroma in Maxillofacial Region: A Series of 16 Cases.

Authors:  Tejinder Kaur; Amit Dhawan; Ramandeep Singh Bhullar; Sakshi Gupta
Journal:  J Maxillofac Oral Surg       Date:  2019-11-08

3.  Large cemento-ossifying fibroma of the mandible involving the infratemporal and parapharyngeal spaces.

Authors:  Shrihari Guddadararangiah; Shishir Ram Shetty; Saad Al-Bayatti; Sangeetha Narasimhan
Journal:  Heliyon       Date:  2021-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.